Search results for "OBESITY"

showing 10 items of 1833 documents

Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities.

2019

BACKGROUND: It has been reported that changes in cardiac structure and ventricular function associated with obesity have to be attributable to hemodynamic and non-hemodynamic alterations. Accordingly, the aim of this was to evaluate left ventricular hypertrophy (LVH) prevalence and its effect on left ventricular systolic and diastolic function in a cohort of obese patients. MATERIALS AND METHODS: LV internal diameter (LVID), left ventricular mass (LVM) and LVM/height2.7(LVMI), relative wall thickness (RWT), LV ejection fraction (LVEF), E/A ratio, isovolumic relaxation time, deceleration time of E velocity by echocardiography and pulsed-wave Doppler and total circulating adiponectin (ADPN) b…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart VentriclesHemodynamics030204 cardiovascular system & hematologyLeft ventricular hypertrophy03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineWaist–hip ratioobesity cardiac structureInternal medicinemedicineHumansCardiac structure030212 general & internal medicineObesityPhenomicsskin and connective tissue diseasesCorrelation of DataEchocardiography Doppler PulsedAdiponectinbusiness.industryCardiometabolic Risk FactorsStroke VolumeGeneral MedicineOrgan SizeMiddle Agedmedicine.diseaseObesityBlood pressureItalyEchocardiographycardiovascular systemCardiologyFemaleHypertrophy Left Ventricularsense organsAdiponectinCardiology and Cardiovascular MedicinebusinessFunction (biology)Acta cardiologica
researchProduct

Non-alcoholic fatty liver disease: Severity of fibrosis and its relationships with clinical and biological variables

2015

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryFatty liverNon alcoholicHeartmedicine.diseaseNon-alcoholic fatty liver disease fibrosis obesityGastroenterologyDisease severityLiverFibrosisNon-alcoholic Fatty Liver DiseaseInternal medicinemedicineHumansFemalebusinessPericardiumUltrasonographyJournal of Hepatology
researchProduct

The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis.

2009

Recent guidelines published by the joint European Society of Hypertension/European Society of Cardiology have suggested the inclusion of C-reactive protein (CRP) in the standard assessment of cardiovascular risk in hypertensive patients, but little data is available on the role of CRP in patients with carotid lesions. We studied in 472 subjects, 236 with and 236 without hypertension, gender- and age-matched, with and without early stages of atherosclerosis (e.g. those with asymptomatic intima-media thickness >0.9 mm), the influence of all the other traditional cardiovascular risk factors (e.g. older age, male gender, obesity, diabetes, smoking habit, family history of coronary artery diseas…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaInflammationAsymptomaticCoronary artery diseasePredictive Value of TestsRisk FactorsInternal medicineDiabetes mellitusCRP Hypertension Subclinical Atherosclerosis atherosclerosisInternal MedicinemedicineHumansIn patientFamily historyAgedbiologybusiness.industryC-reactive proteinMiddle Agedmedicine.diseaseC-reactive protein hypertension inflammation event atherosclerosisAtherosclerosisObesitySettore MED/11 - Malattie Dell'Apparato CardiovascolareCerebrovascular DisordersC-Reactive ProteinCase-Control StudiesHypertensionCardiologybiology.proteinFemalemedicine.symptombusinessBiomarkersFollow-Up StudiesInternal medicine journal
researchProduct

Plasma adiponectin: a contributing factor for cardiac changes in visceral obesity-associated hypertension.

2013

This study has been designed to evaluate the impact of adiponectin levels on left ventricular geometry and function in visceral obesity-associated hypertension. 94 consecutive subjects, 53 of them were hypertensives and 41 normotensives with age <= 65 years, subgrouped according to the presence or absence of visceral obesity, were studied. Total adiponectin levels were measured by a validated competitive radioimmunoassay. Left ventricular telediastolic internal diameter, interventricular septum, posterior wall thickness, total left ventricular mass (LVM) and normalized for height to the 2.7 power (LVM/h(2.7)), relative wall thickness, left ventricular ejection fraction by echocardiography a…

Malemedicine.medical_specialtySettore MED/09 - Medicina Internaobesity-associated hypertensionWaist–hip ratioInternal medicineInternal MedicinemedicineHumansInterventricular septumObesityadiponectinhypertensionobesityAgedEjection fractionAdiponectinbusiness.industryGeneral MedicineMiddle AgedEndocrinologymedicine.anatomical_structureBlood pressureMean blood pressureCardiovascular DiseasesEchocardiographyleft ventricular maObesity AbdominalHypertensionCardiologyFemaleAdiponectinCardiology and Cardiovascular MedicinebusinessIsovolumic relaxation timeBody mass indexBlood pressure
researchProduct

Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve ga…

2019

IntroductionBariatric surgery is increasingly recognised as an effective treatment option for subjects with type 2 diabetes and obesity; however, there is no conclusive evidence on the superiority of Roux-en-Y gastric bypass or sleeve gastrectomy. The Oseberg study was designed to compare the effects of gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function.Methods and analysisSingle-centre, randomised, triple-blinded, two-armed superiority trial carried out at the Morbid Obesity Centre at Vestfold Hospital Trust in Norway. Eligible patients with type 2 diabetes and obesity were randomly allocated in a 1:1 ratio to either gastric bypass or sleeve gastrecto…

Malemedicine.medical_specialtySleeve gastrectomyβ-cell functionmedicine.medical_treatment1843Gastric BypassBariatric Surgery030209 endocrinology & metabolismType 2 diabeteslaw.invention03 medical and health sciences0302 clinical medicineSuperiority TrialRandomized controlled trialClinical ProtocolslawGastrectomyDiabetes mellitusInternal medicineInsulin-Secreting CellsmedicineProtocolHumans030212 general & internal medicine1506VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771Glycated Hemoglobinbusiness.industryNorwayGeneral Medicinemedicine.diseaseRoux-en-Y anastomosismorbid obesityObesity MorbidDiabetes and EndocrinologyTreatment OutcomeDiabetes Mellitus Type 2GastrectomyFemaleLaparoscopytype 2 diabetesbusinessEpidemiologic MethodsBody mass indexrandomised controlled trialsleeve gastrectomy
researchProduct

Insulin resistance as common molecular denominator linking obesity to Alzheimer’s disease

2015

Alzheimer’s disease (AD) is an aging-related multi-factorial disorder to which metabolic factors contribute at what has canonically been considered a centrally mediated process. Although the exact underlying mechanisms are still unknown, obesity is recognized as a risk factor for AD and the condition of insulin resistance seems to be the link between the two pathologies. Using mice with high fat diet (HFD) obesity we dissected the molecular mechanisms shared by the two disorders. Brains of HFD fed mice showed elevated levels of APP and Aβ 40 /Aβ 42 together with BACE, GSK3β and Tau proteins involved in APP processing and Aβ accumulation. Immunofluorescence, Thioflavin T staining experiments…

Malemedicine.medical_specialtyTime FactorsAdipokineAmyloidogenic ProteinsInflammationBiologyDiet High-Fatmedicine.disease_causeAdipokines Alzheimer’s disease gene expression inflammation insulin resistance mitochondrial dysfunction obesity.Settore BIO/09 - FisiologiaGlycogen Synthase Kinase 3MiceInsulin resistanceAlzheimer DiseaseInternal medicinemedicineAnimalsInsulinObesityReceptorGSK3BGlycogen Synthase Kinase 3 betaSettore BIO/16 - Anatomia UmanaNeurodegenerationBrainmedicine.diseaseReceptor InsulinMice Inbred C57BLDisease Models AnimalOxidative StressInsulin receptorEndocrinologyGene Expression RegulationNeurologyCase-Control Studiesbiology.proteinCytokinesNeurology (clinical)Amyloid Precursor Protein SecretasesInsulin Resistancemedicine.symptomOxidative stressSignal Transduction
researchProduct

Obesity modifies the relationship between ambulatory blood pressure and natriuresis in children

2001

The objective in the present study was to evaluate if obesity beginning in the first two decades of life influences the relationship between ambulatory blood pressure and urinary sodium excretion.Eighty-five obese and 88 non-obese children aged 3-19 years were included in the study. For each subject, a 24h ambulatory blood pressure monitoring and a complete urine collection were simultaneously performed according to the protocols designed. The averages of ambulatory blood pressure and of the urinary excretion rates for sodium, potassium and creatinine were calculated separately for 24-h, awake and sleep periods as defined by a mini-diary.Weight and sodium excretion are directly associated w…

Malemedicine.medical_specialtyTime FactorsAmbulatory blood pressureAdolescentNatriuresisAssessment and DiagnosisNatriuresisRisk FactorsInternal medicineInternal MedicinemedicineHumansObesityChildAdvanced and Specialized NursingUrinary sodiumbusiness.industryGeneral MedicineBlood Pressure Monitoring Ambulatorymedicine.diseaseObesityEndocrinologyBlood pressureChild PreschoolCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBlood Pressure Monitoring
researchProduct

Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2

2012

We investigated the potential anorectic action of peripherally administered glucagon-like peptide 2 (GLP2) in lean and diet-induced obese (DIO) mice. Mice, fasted for 16 h, were injected i.p. with native GLP2 or [Gly2]GLP2, stable analog of GLP2, before or after GLP2 (3–33), a GLP2 receptor (GLP2R) antagonist, or exendin (9–39), a GLP1R antagonist. Food intake was measured at intervals 1, 2, 4, 8, and 24 h postinjection. In addition, we tested in lean mice the influence of [Gly2]GLP2 on gastric emptying and the effects of GLP1 alone or in combination with [Gly2]GLP2 on food intake. [Gly2]GLP2 dose dependently and significantly inhibited food intake in lean and DIO mice. The reduction of foo…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismPeptideDiet High-FatSettore BIO/09 - FisiologiaGlucagon-Like Peptide-1 ReceptorEatingMiceEndocrinologyGLP-2 food intake diet induced obesityGlucagon-Like Peptide 1Internal medicineAppetite DepressantsGlucagon-Like Peptide 2Receptors GlucagonmedicineAnimalsObesityReceptorchemistry.chemical_classificationDose-Response Relationship DrugGastric emptyingAntagonistReceptor Cross-TalkGlucagon-like peptide-2Peptide FragmentsMice Inbred C57BLDose–response relationshipEndocrinologyGastric EmptyingchemistryGlucagon-Like Peptide-2 ReceptorAnorecticGlucagon-Like Peptide-2 Receptor
researchProduct

Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index.

2015

Obesity has been shown to be a risk factor for kidney stone formation. Obesity leads to insulin resistance which subsequently leads to low urinary pH. Low urinary pH is typically treated with potassium citrate. We determined if the response to potassium citrate for the treatment of low urinary pH and hypocitraturia varied when patients were stratified by body mass index.We retrospectively reviewed the records of patients with urolithiasis and concomitant hypocitraturia and low urinary pH as unique abnormalities upon metabolic evaluation treated exclusively with potassium citrate. Based on body mass index the cohort was divided into the 4 groups of normal weight, overweight, obese and morbid…

Malemedicine.medical_specialtyUrologyUrinary systemPotassium030232 urology & nephrologyUrologychemistry.chemical_elementOverweightCitric AcidBody Mass Index03 medical and health sciencesKidney Calculi0302 clinical medicineInsulin resistanceInternal medicinePotassium CitratemedicineHumansAgedRetrospective Studiesbusiness.industryHydrogen-Ion ConcentrationMiddle Agedmedicine.diseaseObesityEndocrinologyTreatment Outcomechemistry030220 oncology & carcinogenesisKidney stonesFemalemedicine.symptombusinessHypocitraturiaBody mass indexThe Journal of urology
researchProduct

Effect of Obesity and Being Overweight on Disability and Pain After Lumbar Fusion: An Analysis of 805 Patients.

2016

STUDY DESIGN Prospective follow-up study. OBJECTIVE To investigate the influence of obesity and being overweight on disability and pain of patients undergoing lumbar spinal fusion. SUMMARY OF BACKGROUND DATA Although spinal fusion surgery has been shown to relieve symptoms in several spinal disorders, the influence of obesity on the results remains controversial. METHODS Since January 1, 2008, all patients undergoing lumbar fusion in two hospitals have been invited to participate in a prospective follow-up database. At the end of 2014, the preoperative and 1-year follow-up data of 805 patients were available. Disability was evaluated using the Oswestry Disability Index and back and leg pain…

Malemedicine.medical_specialtyVisual analogue scaleLumbar vertebraeOverweight03 medical and health sciencesDisability Evaluation0302 clinical medicineLumbarmedicineHumansOrthopedics and Sports Medicinepain030212 general & internal medicineObesityProspective StudiesProspective cohort studyAgedPain MeasurementPain PostoperativeLumbar Vertebraebusiness.industryta3141Middle AgedOverweightmedicine.diseaseObesityOswestry Disability Indexlumbar fusionmedicine.anatomical_structureSpinal FusiondisabilityPhysical therapyFemaleNeurology (clinical)medicine.symptombusinessBody mass index030217 neurology & neurosurgeryFollow-Up StudiesSpine
researchProduct